| 1 |
Marcos BFS, de Oliveira THA, Do Amaral CMM, Muniz MTC, Freitas AC, Ahmed S. Correlation between HPV PCNA, p16, and p21 Expression in Lung Cancer Patients. Cellular Microbiology 2022;2022:1-13. [DOI: 10.1155/2022/9144334] [Reference Citation Analysis]
|
| 2 |
Zhang L, Wang R, Xie Z. The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol. [DOI: 10.1007/s00253-022-12029-3] [Reference Citation Analysis]
|
| 3 |
Lin HP, Rea M, Wang Z, Yang C. Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property. Toxicol Appl Pharmacol 2021;430:115724. [PMID: 34520792 DOI: 10.1016/j.taap.2021.115724] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Zheng S, Wang C, Yan H, Du Y. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis. Bioengineered 2021;12:8347-57. [PMID: 34592879 DOI: 10.1080/21655979.2021.1987053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 5 |
Zhang Q, Liu F, Chen W, Miao H, Liang H, Liao Z, Zhang Z, Zhang B. The role of RNA m5C modification in cancer metastasis. Int J Biol Sci 2021;17:3369-80. [PMID: 34512153 DOI: 10.7150/ijbs.61439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 6 |
Min HY, Lee HY. Mechanisms of resistance to chemotherapy in non-small cell lung cancer. Arch Pharm Res 2021;44:146-64. [PMID: 33608812 DOI: 10.1007/s12272-021-01312-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 7 |
Cui H, Arnst K, Miller DD, Li W. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance. CMC 2020;27:6573-95. [DOI: 10.2174/0929867326666191016113631] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 8 |
Bae HJ, Kang SK, Kwon WS, Jeong I, Park S, Kim TS, Kim KH, Kim H, Jeong HC, Chung HC, Rha SY. p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer. Biochem Pharmacol 2021;183:114320. [PMID: 33161023 DOI: 10.1016/j.bcp.2020.114320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Li Y, Zhang T, Zhang H, Wang X, Liu X, Huang Q, Li L. Clinical Significance of P16 Gene Methylation in Lung Cancer. Adv Exp Med Biol 2020;1255:133-42. [PMID: 32949396 DOI: 10.1007/978-981-15-4494-1_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Sarne V, Huter S, Braunmueller S, Rakob L, Jacobi N, Kitzwögerer M, Wiesner C, Obrist P, Seeboeck R. Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines. Int J Mol Sci 2020;21:E4595. [PMID: 32605217 DOI: 10.3390/ijms21134595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Wang SM, Kong XY, Li M, Sun LL, Yan D. Association of GGH Promoter Methylation Levels with Methotrexate Concentrations in Chinese Children with Acute Lymphoblastic Leukemia. Pharmacotherapy 2020;40:614-22. [PMID: 32476160 DOI: 10.1002/phar.2430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Wang SM, Li M, Wu WS, Sun LL, Yan D. Methylation analysis of the SLC19A1 promoter region in Chinese children with acute lymphoblastic leukaemia. J Clin Pharm Ther 2020;45:646-51. [PMID: 32403197 DOI: 10.1111/jcpt.13171] [Reference Citation Analysis]
|
| 13 |
Zhang J, Luo L, Dong J, Liu M, Zhai D, Huang D, Ling L, Jia X, Luo K, Zheng G. A prognostic 11-DNA methylation signature for lung squamous cell carcinoma. J Thorac Dis 2020;12:2569-82. [PMID: 32642165 DOI: 10.21037/jtd.2020.03.31] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Liu X, Tang C, Song X, Cheng L, Liu Y, Ding F, Xia C, Xue L, Xiao J, Huang B. Clinical value of CTLA4-associated microRNAs combined with inflammatory factors in the diagnosis of non-small cell lung cancer. Ann Clin Biochem 2020;57:151-61. [PMID: 31906699 DOI: 10.1177/0004563220901564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 15 |
Gu C, Chen C. Methylation in Lung Cancer: A Brief Review. Methods Mol Biol 2020;2204:91-7. [PMID: 32710317 DOI: 10.1007/978-1-0716-0904-0_8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 16 |
Li P, Zhang X, Gu L, Zhou J, Deng D. P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib. PLoS One 2019;14:e0223084. [PMID: 31652270 DOI: 10.1371/journal.pone.0223084] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 17 |
Li P, Zhang X, Gu L, Zhou J, Deng D. P16methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib.. [DOI: 10.1101/771337] [Reference Citation Analysis]
|
